Bing Wu, MD, PHD | |
1116 N 16th St, Ste. A, Lafayette, IN 47904-2119 | |
(765) 448-8000 | |
(765) 448-8054 |
Full Name | Bing Wu |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 40 Years |
Location | 1116 N 16th St, Lafayette, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346455110 | NPI | - | NPPES |
000000676054 | Other | IN | ANTHEM PROVIDER NUMBER |
200982460 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 35089204 (Ohio) | Secondary |
207RC0000X | Internal Medicine - Cardiovascular Disease | 01067685A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Indiana University Health Arnett Hospital | Lafayette, IN | Hospital |
Indiana University Health White Memorial Hospital | Monticello, IN | Hospital |
Indiana University Health Frankfort Inc | Frankfort, IN | Hospital |
Indiana University Health | Indianapolis, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Arnett Clinic Llc | 0749184380 | 380 |
News Archive
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec today announced that three-year follow up of the pivotal Phase III CLL8 trial showed Rituxan plus fludarabine and cyclophosphamide (FC) chemotherapy helped patients in the trial with previously untreated chronic lymphocytic leukemia (CLL) live longer than FC alone.
Texas Biomedical Research Institute Staff Scientist Dr. Genesio Karere was recently awarded a $609,568 grant from the National Institutes of Health to study and identify molecular mechanisms underlying early atherosclerosis.
China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced that the Company has obtained approval from the State Food and Drug Administration in China for the production of Ciclopirox Olamine Vaginal Suppositories.
For patients with severe psoriasis, a new class of intravenous and injectable biological medicines known as "biologics" has brought about a near revolution in treatment.
› Verified 6 days ago
Entity Name | Arnett Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164490843 PECOS PAC ID: 0749184380 Enrollment ID: O20031125000119 |
News Archive
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec today announced that three-year follow up of the pivotal Phase III CLL8 trial showed Rituxan plus fludarabine and cyclophosphamide (FC) chemotherapy helped patients in the trial with previously untreated chronic lymphocytic leukemia (CLL) live longer than FC alone.
Texas Biomedical Research Institute Staff Scientist Dr. Genesio Karere was recently awarded a $609,568 grant from the National Institutes of Health to study and identify molecular mechanisms underlying early atherosclerosis.
China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced that the Company has obtained approval from the State Food and Drug Administration in China for the production of Ciclopirox Olamine Vaginal Suppositories.
For patients with severe psoriasis, a new class of intravenous and injectable biological medicines known as "biologics" has brought about a near revolution in treatment.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Bing Wu, MD, PHD 1200 W White River Blvd, Muncie, IN 47303-4988 Ph: (877) 668-5621 | Bing Wu, MD, PHD 1116 N 16th St, Ste. A, Lafayette, IN 47904-2119 Ph: (765) 448-8000 |
News Archive
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec today announced that three-year follow up of the pivotal Phase III CLL8 trial showed Rituxan plus fludarabine and cyclophosphamide (FC) chemotherapy helped patients in the trial with previously untreated chronic lymphocytic leukemia (CLL) live longer than FC alone.
Texas Biomedical Research Institute Staff Scientist Dr. Genesio Karere was recently awarded a $609,568 grant from the National Institutes of Health to study and identify molecular mechanisms underlying early atherosclerosis.
China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced that the Company has obtained approval from the State Food and Drug Administration in China for the production of Ciclopirox Olamine Vaginal Suppositories.
For patients with severe psoriasis, a new class of intravenous and injectable biological medicines known as "biologics" has brought about a near revolution in treatment.
› Verified 6 days ago
Michelle B Herberts, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-8564 | |
Dr. Carlos Salazar Carcamo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-583-2444 | |
Maria L Srour, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 5165 Mccarty Ln, Lafayette, IN 47905 Phone: 765-448-8000 Fax: 765-448-7631 | |
Steven Rudolf Steinhubl, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5177 Mccarty Ln, Lafayette, IN 47905 Phone: 765-448-8000 Fax: 765-838-4333 | |
Michael Leo Hogan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3900 St Francis Way Ste 200, Lafayette, IN 47905 Phone: 765-775-2800 Fax: 765-775-2831 | |
Carlos A Gambirazio, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 Greenbush St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-7624 | |
Dr. Christopher Patrick Kaup, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 Ferry St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-838-4698 |